by nikki mann | Dec 8, 2021 | News
The President of Cyprus, Nicos Anastasiades, presented our Director Tony Kouzarides with the prestigious Excellence in Science Award this week, on behalf of the Cyprus Academy of Science. The ceremony took place at the Presidential Palace in Cyprus, during...
by nikki mann | Nov 26, 2021 | News
This week, Deputy Director Kathryn Chapman and Communications Manager Nikki Mann represented the Milner team at the OBN Awards in Oxford, and we are delighted to announce that the Milner Therapeutics Institute won in the category for Most Impactful Business Support...
by nikki mann | Nov 12, 2021 | News
We are delighted to share that KPBMA (Korea Pharmaceutical and Bio-Pharma Manufacturers Association) has joined as an Affiliated Organization of the Milner Therapeutics Institute today. KPBMA is the largest industry member organization in South Korea, which is based...
by nikki mann | Oct 11, 2021 | News
We are delighted to announce that Astellas have joined the Milner Therapeutics Consortium as our 11th pharma partner. Astellas, a global pharmaceutical company headquartered in Japan, works across more than 70 countries in the US, Europe and Asia. They bring to the...
by nikki mann | Oct 6, 2021 | News
We are proud to announce that the Milner Therapeutics Institute has been shortlisted for a 2021 OBN Award in the category for Most Impactful Business Support Organisation. The OBN Awards, now in their 13th year, celebrate individuals and life sciences companies that...
by nikki mann | Aug 4, 2021 | News
Research in the Tzelepis lab, in collaboration with scientists from the Wellcome Sanger Institute and Harvard University, has identified a protein that plays a key role in transforming normal tissue to cancerous, as a possible target for drug development. The...
